Operating Lease, Right-of-Use Asset of Viridian Therapeutics, Inc.\DE from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Viridian Therapeutics, Inc.\DE quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Viridian Therapeutics, Inc.\DE Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,582,000, a 7.6% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Viridian Therapeutics, Inc.\DE Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,582,000 +$182,000 +7.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,977,000 +$151,000 +8.3% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,092,000 +$610,000 +41% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $2,205,000 +$535,000 +32% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $2,400,000 +$545,000 +29% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,826,000 -$244,000 -12% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,482,000 +$14,000 +0.95% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,670,000 +$60,000 +3.7% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $1,855,000 +$608,000 +49% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $2,070,000 +$665,000 +47% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,468,000 -$75,000 -4.9% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $1,610,000 -$70,000 -4.2% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $1,247,000 -$214,000 -15% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,405,000 -$162,000 -10% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,543,000 -$57,000 -3.6% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $1,680,000 +$1,202,000 +251% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $1,461,000 +$971,000 +198% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $1,567,000 +$983,000 +168% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,600,000 +$1,334,000 +502% 31 Mar 2021 10-Q 08 Aug 2024 2024 Q2
Q4 2020 $478,000 +$478,000 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $490,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $584,000 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $266,000 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $0 31 Dec 2019 10-Q 12 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.